Your browser doesn't support javascript.
loading
Constrained Optimization for Pneumococcal Vaccination in Brazil.
Olbrecht, Jan; Gomez, Jorge A; Van Bellinghen, Laure-Anne; Van Vlaenderen, Ilse; Standaert, Baudouin.
Afiliação
  • Olbrecht J; GlaxoSmithKline, Wavre, Belgium. Electronic address: j_olbrecht@hotmail.com.
  • Gomez JA; GlaxoSmithKline, Victoria, Argentina.
  • Van Bellinghen LA; CHESS In Health, Bonheiden, Belgium.
  • Van Vlaenderen I; CHESS In Health, Bonheiden, Belgium.
  • Standaert B; GlaxoSmithKline, Wavre, Belgium; HEBO, Antwerpen, Belgium.
Value Health Reg Issues ; 26: 40-49, 2021 Dec.
Article em En | MEDLINE | ID: mdl-33848895
OBJECTIVES: To identify the most cost-efficient combination of pneumococcal vaccines in infants and aging adults for a 10-year period in Brazil. METHODS: Constrained optimization (CO) prioritized 9 pneumococcal vaccine regimens according to their gain in quality-adjusted life-years (QALYs) and their related costs over a prespecified time horizon with defined constraints for 2 age groups, infants and aging adults. The analysis starts from the current universal infant vaccination of pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV), 2 primary and 1 booster dose at 2, 4, and 12 months, respectively. Key constraints are the fixed annual vaccine budget increase and the relative return on investment (ROIR) per regimen, which must be > 1, the reference intervention being the current vaccination strategy in infants and the most cost-efficient one in aging adults. RESULTS: The CO analysis including all the constraints indicates that over 10 years the maximum extra health gain is 126 194 QALYs for an extra budget of $974 million Brazilian reals (ROIR = 1.15). Results could be improved with a higher proportion of the at-risk population in aging adults, less herd effect, and better QALY scores. CONCLUSION: The study shows that with 4 constraints on budget, time horizon, vaccine coverage, and cost efficiency, a CO analysis could identify the most cost-efficient overall pneumococcal vaccination strategy for Brazil, allowing for limited vaccine budget increase while obtaining appropriate health gain.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Limite: Adult / Humans / Infant País/Região como assunto: America do sul / Brasil Idioma: En Revista: Value Health Reg Issues Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Limite: Adult / Humans / Infant País/Região como assunto: America do sul / Brasil Idioma: En Revista: Value Health Reg Issues Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos